🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 3 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/03/2022 83,46 85,05 83,12 84,45 +1,53% 2,31% 818.800
08/03/2022 79,68 84,32 78,40 83,18 +3,43% 7,43% 839.900
07/03/2022 78,44 82,46 77,86 80,42 +1,34% 5,86% 784.400
04/03/2022 81,03 81,43 77,76 79,36 -2,59% 4,53% 1.117.400
03/03/2022 79,48 83,14 79,26 81,47 +2,40% 4,88% 967.600
02/03/2022 79,87 83,29 77,04 79,56 +4,66% 7,83% 1.166.600
01/03/2022 76,10 76,57 74,00 76,02 -0,77% 3,38% 692.000
28/02/2022 75,01 76,86 74,51 76,61 +0,76% 3,13% 889.200
25/02/2022 75,37 76,70 74,77 76,03 +0,28% 2,56% 610.000
24/02/2022 71,36 76,05 71,24 75,82 +3,00% 6,74% 913.200
23/02/2022 75,62 76,10 73,43 73,61 -1,91% 3,53% 447.400
22/02/2022 73,61 76,57 72,96 75,04 +0,62% 4,90% 533.900
18/02/2022 75,97 77,26 74,19 74,58 -2,69% 4,04% 570.000
17/02/2022 79,34 79,88 76,49 76,64 -4,19% 4,27% 678.600
16/02/2022 80,98 81,32 79,47 79,99 -1,67% 2,28% 510.300
15/02/2022 80,21 81,96 80,21 81,35 +3,46% 2,18% 590.700
14/02/2022 80,03 81,59 78,59 78,63 -1,99% 3,75% 607.400
11/02/2022 79,04 81,94 78,58 80,23 +1,94% 4,25% 713.700
10/02/2022 77,93 81,26 76,52 78,70 -0,24% 6,08% 1.104.600
09/02/2022 75,85 79,10 75,02 78,89 +4,61% 5,38% 696.600
08/02/2022 75,59 76,14 74,06 75,41 -0,71% 2,75% 561.800
07/02/2022 73,11 77,05 72,59 75,95 +3,88% 6,10% 645.500
04/02/2022 69,22 73,70 69,05 73,11 +5,22% 6,72% 702.200
03/02/2022 71,04 71,60 69,19 69,48 -2,72% 3,39% 489.600
02/02/2022 73,94 73,97 71,00 71,42 -3,81% 4,02% 524.400
01/02/2022 71,40 74,34 70,01 74,25 +3,74% 6,06% 964.500
31/01/2022 69,77 71,59 69,62 71,57 +2,70% 2,82% 800.900
28/01/2022 67,07 69,70 65,64 69,69 +4,20% 6,05% 662.700
27/01/2022 71,28 71,41 66,44 66,88 -4,78% 6,97% 1.127.700
26/01/2022 69,58 72,38 68,79 70,24 +2,23% 5,16% 1.274.800